Business Description
Radiopharm Theranostics is an Australian medical research company focused on developing radiation-based drugs to detect and treat serious cancers, including breast cancer, lung cancer, prostate cancer, and brain tumors. Founded in 2021 and headquartered in Carlton, the company is building a broad portfolio of products designed to address cancers that currently have few effective treatment options. Radiopharm works alongside Lantheus Holdings to move its pipeline of diagnostic and therapeutic candidates through clinical development.
